Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus

Intra-articular corticosteroid injections may cause hyperglycemia (glucose level >180 mg/dL). In a phase 2 study of 33 patients who had osteoarthritis of the knee and type 2 diabetes mellitus, triamcinolone acetonide extended-release (TA-ER) was associated with minimal glycemic control disruption...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of arthroplasty 2024-09, Vol.39 (9), p.S218-S223.e1
Hauptverfasser:	Spitzer, Andrew I., Rodbard, Helena W., Iqbal, Sheikh Usman, Nakazawa, Masato, DiGiorgi, Mary, Winston, Roy
Format:	Artikel
Sprache:	eng
Schlagworte:	hyperglycemia intra-articular injection knee osteoarthritis triamcinolone acetonide extended-release type 2 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!